Varaico: Literature-Extracted Genetic Variants

Gene:RRAS2
Variant:p.A70T
Back to variants list

RRAS2

NM_012250.6:p.A70T

Associated Papers

MOLGENIS VIP: an end-to-end DNA variant interpretation pipeline for research and diagnostics configurable to support rapid implementation of new methods.

Maassen WTK et al.

Nar Genomics and Bioinformatics, 2025

40585303 (PubMed )
Supplement: lqaf087_supplemental_files.zip › supplementary_table_3.pdf

The RRAS2 pathogenic variant (c.67G>T; p. Gly23Cys) produces Noonan syndrome with embryonal rhabdomyosarcoma.

Zeng L et al.

Molecular Genetics & Genomic Medicine, 2024

Identification of a novel frameshift variation in ANKRD11: a case report of KBG syndrome.

Shao Q et al.

Frontiers in Genetics, 2024

Mice Overexpressing Wild-Type RRAS2 Are a Novel Model for Preclinical Testing of Anti-Chronic Lymphocytic Leukemia Therapies.

Hortal AM et al.

Cancers, 2023

Characterization of mutant versions of the R-RAS2/TC21 GTPase found in tumors.

Clavaín L et al.

Oncogene, 2023

The molecular genetics of RASopathies: An update on novel disease genes and new disorders.

Tartaglia M et al.

American Journal of Medical Genetics. Part C, Seminars in Medical Genetics, 2022

Are transient protein-protein interactions more dispensable?

Ghadie MA et al.

Plos Computational Biology, 2022

35404956 (PubMed )
Supplement: pcbi.1010013.s002.xlsx › _B__Y2H-SI_disMut_edgotypes

The RASopathies: from pathogenetics to therapeutics.

Hebron KE et al.

Disease Models & Mechanisms, 2022

Structural bioinformatics enhances mechanistic interpretation of genomic variation, demonstrated through the analyses of 935 distinct RAS family mutations.

Tripathi S et al.

Bioinformatics (oxford, England), 2021

33226070 (PubMed )
Supplement: btaa972_supplementary_data.zip › RAS_Manuscript_RMarkdown.tar.gz › RAS_Manuscript1.Revised › RAS_Variants_Scores.xlsx › Sheet1

Mutation Edgotype Drives Fitness Effect in Human.

Ghadie M et al.

Frontiers in Bioinformatics, 2021

36303776 (PubMed )
Supplement: Table2.XLSX › _B__Y2H-SI_pathMt_edgotype

The Immunogenic Potential of Recurrent Cancer Drug Resistance Mutations: An In Silico Study.

Punta M et al.

Frontiers in Immunology, 2020

33133066 (PubMed )
Supplement: Table_1.xlsx › Drivers-not-HR

Activating Mutations of RRAS2 Are a Rare Cause of Noonan Syndrome.

Capri Y et al.

American Journal of Human Genetics, 2019

Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."